Return to study ST003281 main page

Download data matrix(Phosphate availability conditions caspofungin tolerance, capsule attachment and titan cell formation in Cryptococcus neoformans HILIC NEGATIVE ION MODE)

Download data matrix(Phosphate availability conditions caspofungin tolerance, capsule attachment and titan cell formation in Cryptococcus neoformans Reversed phase NEGATIVE ION MODE)

AnalysisSamplesFactorsUnits
HILIC NEGATIVE ION MODEH99-iron-20Pi-24h_AGenotype:H99 | Treatment:H99-iron-20Pi-24h | Sample source:CellsRel Abundance
HILIC NEGATIVE ION MODEH99-iron-20Pi-24h_BGenotype:H99 | Treatment:H99-iron-20Pi-24h | Sample source:CellsRel Abundance
HILIC NEGATIVE ION MODEH99-iron-20Pi-24h_CGenotype:H99 | Treatment:H99-iron-20Pi-24h | Sample source:CellsRel Abundance
HILIC NEGATIVE ION MODEH99-iron-20Pi-24h_DGenotype:H99 | Treatment:H99-iron-20Pi-24h | Sample source:CellsRel Abundance
HILIC NEGATIVE ION MODEH99-iron-20Pi-6h_AGenotype:H99 | Treatment:H99-iron-20Pi-6h | Sample source:CellsRel Abundance
HILIC NEGATIVE ION MODEH99-iron-20Pi-6h_BGenotype:H99 | Treatment:H99-iron-20Pi-6h | Sample source:CellsRel Abundance
HILIC NEGATIVE ION MODEH99-iron-20Pi-6h_CGenotype:H99 | Treatment:H99-iron-20Pi-6h | Sample source:CellsRel Abundance
HILIC NEGATIVE ION MODEH99-iron-20Pi-6h_DGenotype:H99 | Treatment:H99-iron-20Pi-6h | Sample source:CellsRel Abundance
HILIC NEGATIVE ION MODEH99-iron-24h_AGenotype:H99 | Treatment:H99-iron-24h | Sample source:CellsRel Abundance
HILIC NEGATIVE ION MODEH99-iron-24h_BGenotype:H99 | Treatment:H99-iron-24h | Sample source:CellsRel Abundance
HILIC NEGATIVE ION MODEH99-iron-24h_CGenotype:H99 | Treatment:H99-iron-24h | Sample source:CellsRel Abundance
HILIC NEGATIVE ION MODEH99-iron-24h_DGenotype:H99 | Treatment:H99-iron-24h | Sample source:CellsRel Abundance
HILIC NEGATIVE ION MODEH99-iron-6h_AGenotype:H99 | Treatment:H99-iron-6h | Sample source:CellsRel Abundance
HILIC NEGATIVE ION MODEH99-iron-6h_BGenotype:H99 | Treatment:H99-iron-6h | Sample source:CellsRel Abundance
HILIC NEGATIVE ION MODEH99-iron-6h_CGenotype:H99 | Treatment:H99-iron-6h | Sample source:CellsRel Abundance
HILIC NEGATIVE ION MODEH99-iron-6h_DGenotype:H99 | Treatment:H99-iron-6h | Sample source:CellsRel Abundance
HILIC NEGATIVE ION MODEH99-no iron-20Pi-6h_AGenotype:H99 | Treatment:H99-no iron-20Pi-6h | Sample source:CellsRel Abundance
HILIC NEGATIVE ION MODEH99-no iron-20Pi-6h_BGenotype:H99 | Treatment:H99-no iron-20Pi-6h | Sample source:CellsRel Abundance
HILIC NEGATIVE ION MODEH99-no iron-20Pi-6h_CGenotype:H99 | Treatment:H99-no iron-20Pi-6h | Sample source:CellsRel Abundance
HILIC NEGATIVE ION MODEH99-no iron-20Pi-6h_DGenotype:H99 | Treatment:H99-no iron-20Pi-6h | Sample source:CellsRel Abundance
HILIC NEGATIVE ION MODEH99-no iron-6h_AGenotype:H99 | Treatment:H99-no iron-6h | Sample source:CellsRel Abundance
HILIC NEGATIVE ION MODEH99-no iron-6h_BGenotype:H99 | Treatment:H99-no iron-6h | Sample source:CellsRel Abundance
HILIC NEGATIVE ION MODEH99-no iron-6h_CGenotype:H99 | Treatment:H99-no iron-6h | Sample source:CellsRel Abundance
HILIC NEGATIVE ION MODEH99-no iron-6h_DGenotype:H99 | Treatment:H99-no iron-6h | Sample source:CellsRel Abundance
HILIC NEGATIVE ION MODEQC1Genotype:H99 | Treatment:QC | Sample source:CellsRel Abundance
HILIC NEGATIVE ION MODEQC2Genotype:H99 | Treatment:QC | Sample source:CellsRel Abundance
HILIC NEGATIVE ION MODEQC3Genotype:H99 | Treatment:QC | Sample source:CellsRel Abundance
HILIC NEGATIVE ION MODEQC4Genotype:H99 | Treatment:QC | Sample source:CellsRel Abundance
HILIC NEGATIVE ION MODEQC5Genotype:H99 | Treatment:QC | Sample source:CellsRel Abundance
Reversed phase NEGATIVE ION MODEH99-0_AGenotype:H99 | Treatment:0 | Sample source:CellsRel Abundance
Reversed phase NEGATIVE ION MODEH99-0_BGenotype:H99 | Treatment:0 | Sample source:CellsRel Abundance
Reversed phase NEGATIVE ION MODEH99-0_CGenotype:H99 | Treatment:0 | Sample source:CellsRel Abundance
Reversed phase NEGATIVE ION MODEH99-250_AGenotype:H99 | Treatment:250 | Sample source:CellsRel Abundance
Reversed phase NEGATIVE ION MODEH99-250_BGenotype:H99 | Treatment:250 | Sample source:CellsRel Abundance
Reversed phase NEGATIVE ION MODEH99-250_CGenotype:H99 | Treatment:250 | Sample source:CellsRel Abundance
Reversed phase NEGATIVE ION MODEPho-0_AGenotype:Pho | Treatment:0 | Sample source:CellsRel Abundance
Reversed phase NEGATIVE ION MODEPho-0_BGenotype:Pho | Treatment:0 | Sample source:CellsRel Abundance
Reversed phase NEGATIVE ION MODEPho-0_CGenotype:Pho | Treatment:0 | Sample source:CellsRel Abundance
Reversed phase NEGATIVE ION MODEPho-250_AGenotype:Pho | Treatment:250 | Sample source:CellsRel Abundance
Reversed phase NEGATIVE ION MODEPho-250_BGenotype:Pho | Treatment:250 | Sample source:CellsRel Abundance
Reversed phase NEGATIVE ION MODEPho-250_CGenotype:Pho | Treatment:250 | Sample source:CellsRel Abundance
Reversed phase NEGATIVE ION MODEQCL1Genotype:QC | Treatment:QC | Sample source:CellsRel Abundance
Reversed phase NEGATIVE ION MODEQCL2Genotype:QC | Treatment:QC | Sample source:CellsRel Abundance
Reversed phase NEGATIVE ION MODEQCL3Genotype:QC | Treatment:QC | Sample source:CellsRel Abundance
  logo